(Q44441030)

English

Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

scientific article published on June 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production (English)

1 reference

Europe PubMed Central

3 December 2017

Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production (English)

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

0 references

0 references

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

prostate neoplasm

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746841

2 January 2024

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Christian Bailly

4

object named as

Christian Bailly

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746841

2 January 2024

author name string

Murielle Mimeault

1

1 reference

Europe PubMed Central

3 December 2017

Nicole Pommery

2

1 reference

Europe PubMed Central

3 December 2017

Nicole Wattez

3

1 reference

Europe PubMed Central

3 December 2017

Jean-Pierre Hénichart

5

1 reference

Europe PubMed Central

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2003

1 reference

Europe PubMed Central

3 December 2017

15 June 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12746841

2 January 2024

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.10190

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.10190

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

1 reference

Europe PubMed Central

3 December 2017

56

1 reference

Europe PubMed Central

3 December 2017

1

1 reference

Europe PubMed Central

3 December 2017

1-12

1 reference

Europe PubMed Central

3 December 2017

Molecular and cellular biology of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Androgen deprivation as a strategy for prostate cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Ceramide: a new second messenger of cannabinoid action

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Human acid ceramidase is overexpressed but not mutated in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Chondrocyte necrosis and apoptosis in impact damaged articular cartilage

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10190

21 January 2018

EGF receptor signaling in prostate morphogenesis and tumorigenesis

2

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Prostate cancer prevention: investigational approaches and opportunities

3

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

9

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma

10

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor

11

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.

12

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Δ9 -Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

23

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors

27

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor

28

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

A NEW PROCEDURE FOR STAINING VAGINAL SMEARS

29

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis.

31

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications

35

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells

38

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts

39

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation

40

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein

41

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques

44

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Application of Ultrafast Papanicolaou stain to body fluid cytology.

49

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Comparison of ThinPrep and conventional preparations on fine needle aspiration cytology material

50

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

51

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis.

52

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy

54

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Programmed cell death as a new target for prostatic cancer therapy

56

1 reference

10.1002/PROS.10190

https://api.crossref.org/works/10.1002/PROS.10190

2 January 2024

Identifiers

10.1002/PROS.10190

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44441030&oldid=2043220250"